Sign in Create account
Sign in and upgrade to a paid plan to export futures history as CSV.

Triochem Products Ltd.

Healthcare · Pharmaceuticals & Biotechnology

BSE: 512101
₹17.40
▲ 0.30 (1.75%)
Sept. 24, 2015 · BSE · bse_bhavcopy
Quality
80/100
Strong
Valuation
100/100
Undervalued
Momentum
96/100
Bullish

QVM read Strong on all three Quality Strong, Valuation Undervalued, Momentum Bullish

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹0 Cr
PE (TTM)
0.1
Industry median 36.1 (152 companies)
Price to Book
0.0
PEG (TTM)
0.0
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
12.6
Relative return vs Sector, qtr %
3.6
Free Cash Flow
₹-3 Cr
as of March 31, 2026
Industry median ₹-0 Cr (198 companies)
EPS Growth (YoY)
409.60%
as of June 30, 2026
Industry median 26.14% (180 companies)
Net Profit Growth (TTM)
3300.00%
as of June 30, 2026
Industry median 6.21% (175 companies)
Operating Revenue Growth (TTM)
0.00%
as of June 30, 2026
Industry median 9.08% (175 companies)
Profit Growth (YoY)
1942.04%
as of March 31, 2026
Industry median 22.20% (176 companies)
Revenue Growth (YoY)
-68.38%
as of March 31, 2022
Industry median 14.05% (173 companies)
Current Ratio
416.38
as of March 31, 2026
Industry median 1.84 (197 companies)
Debt to Equity
0.00
as of March 31, 2026
Industry median 0.14 (186 companies)
Interest Coverage
137.12
as of June 30, 2026
Industry median 10.58 (182 companies)
Net Margin
25.92%
as of March 31, 2022
Industry median 9.35% (179 companies)
Operating Margin (EBIT)
35.44%
as of March 31, 2022
Industry median 14.22% (181 companies)
Operating Margin (TTM)
65.67%
as of June 30, 2026
Industry median 12.41% (182 companies)
Return on Assets
36.61%
as of March 31, 2026
Industry median 5.54% (180 companies)
Return on Capital Employed
50.83%
as of March 31, 2026
Industry median 12.43% (181 companies)
Return on Equity
37.02%
as of March 31, 2026
Industry median 9.66% (179 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

4 of 6 met
  • No Revenue is higher than a year earlier in each of the last 4 quarters
  • Yes Quality score is Strong (70 or more)
  • Yes Debt to equity is below 0.5 (0.00)
  • Yes Return on equity is 15% or more (37.0%)
  • Yes Net cash flow for the latest year is positive
  • No Cash from operations is higher than the year before

Ownership

2 of 2 met
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Peer comparison

2 of 3 met
  • Yes 1-year return beats the industry median
  • No Revenue growth beats the industry median
  • Yes Profit growth beats the industry median

Value and momentum

3 of 4 met
  • Yes Price sits in the Buy zone of its own historical PE range (Buy Zone)
  • Yes Valuation score is Undervalued (70 or more)
  • Yes Momentum score is Bullish (70 or more)
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

Relative Returns (vs SENSEX)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
1.8%
Low 17.4000 · High 17.4000
1W return
1.8%
Low 17.4000 · High 17.4000
1M return
3.6%
Low 17.1000 · High 17.4000
52W return
5.5%
Low 16.8000 · High 17.4000
Lifetime High ₹17.4000 (Sept. 24, 2015)
Lifetime Low ₹12.1200 (Sept. 10, 2008)

Full price history and technicals →

Technicals

Full technicals, indicators & Volume/Delivery →

EMA & SMA

Bullish2
Bearish0
5D
16.8
10D
16.1

Delivery and volume

Day avg. delivery
100.0%
Week avg. delivery
100.0%
Month avg. delivery
100.0%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

17.40
Pivot
First resistance17.40
Second resistance17.40
Third resistance17.40
First support17.40
Second support17.40
Third support17.40
Day RSI95.6
Day MFI100.0
Day MACD—
Day MACD signal—

Beta

1M—
3M—
1Y—
3Y—

Price change analysis

↑ 3.6%
Over 1 Month
LowHigh
17.1017.40
↑ 3.6%
Over 3 Months
LowHigh
17.1017.40
↑ 5.5%
Over 6 Months
LowHigh
16.8017.40
↑ 5.5%
Over 1 Year
LowHigh
16.8017.40
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →
Current PE 0.1 (own history: 0.1–82.9)
Buy Zone

Financials

View full financials, peers & valuation multiples →
Revenue (June 30, 2026)
₹0 Cr
Net profit (June 30, 2026)
₹0 Cr
Basic EPS (June 30, 2026)
₹3.8700

Ranks #184 of 184 in Pharmaceuticals & Biotechnology by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter68.65%

Largest holders

NameCategoryShares %Shares
GRACE R DEORAPromoter14.6900%36000
RAJESH RAMU DEORAPromoter14.6900%36000
RAMU SITARAM DEORAPromoter14.0800%34500
RAJIV RAMU DEORAPromoter13.9900%34270
RAMU MAHABIRPRASAD DEORA HUFPromoter11.1900%27420

As of June 30, 2026. Only holders the filing discloses individually.

Historical promoter holding

Promoters holdings were unchanged at 68.65% in Jun 2026 qtr

All shareholding details →

Deals (Bulk & Block)

All 9 deals, with filters and CSV →
DateClientDealActionQuantityPriceExchange
27 Sep 2012 RAMESH RAJARAM PATIL Bulk Sell 6,700 14.7000 BSE
27 Sep 2012 MEHRANGARH FINANCIAL ADVISORS PRIVATE LIMITED Bulk Buy 6,700 14.7000 BSE
9 Aug 2012 RAMESH RAJARAM PATIL Bulk Sell 4,200 13.8700 BSE
9 Aug 2012 AMBERNATH PLASTO PACKAGING PRIVATE LIMITED Bulk Buy 4,200 13.8700 BSE
25 Jul 2012 KISHORE RADHESHAM CHOKHANI Bulk Sell 2,000 13.6000 BSE
25 Jul 2012 N L RUNGTA HUF Bulk Buy 2,000 13.6000 BSE
25 Jul 2012 BADRI PRASAD CHOUDHURY Bulk Sell 2,500 13.6000 BSE
25 Jul 2012 RAPID STOCKS PVT.LTD. Bulk Buy 2,500 13.6000 BSE
17 May 2012 SUNEXPORTPRIVATELIMITED Bulk Sell 2,400 13.8400 BSE

All bulk and block deals →

Corporate Announcements

All 1 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
30 Sep 2026 Insider Trading / SAST Triochem Products Ltd - 512101 - Closure of Trading Window

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • High Return on Equity (37.0%)
  • Strong net profit margin (25.9%)
  • Low financial leverage (Debt/Equity 0.00)
  • Comfortable interest coverage (137.1x)

Weaknesses

  • Declining revenue YoY (-68.4%)

Opportunities

  • PEG below 1 (0.00) -- earnings growth outpacing its own valuation
  • PE below 15 (0.1) relative to a typical growth business
  • Trading below book value (PB 0.02)

Threats

  • RSI in overbought territory (95.6)

Board of directors and corporate information →

F&O

View F&O, Options & Backtest →

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Triochem Products Ltd.

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.